Breaking News Instant updates and real-time market news.

CVS

CVS Health

$74.78

0.72 (0.97%)

, UNH

UnitedHealth

$152.11

-0.7 (-0.46%)

08:50
11/29/16
11/29
08:50
11/29/16
08:50

OptumRx, CVS Pharmacy form partnership

OptumRx and CVS Pharmacy are partnering to provide more convenient choices and lower costs for consumers and clients while improving health outcomes. OptumRx is UnitedHealth Group's (UNH) free-standing pharmacy care services business, managing more than one billion prescriptions annually. CVS Pharmacy, the retail division of CVS Health (CVS), is America's leading retail pharmacy, with more than 9,600 retail pharmacies across the nation. The strategic relationship will bring together complementary capabilities to provide greater convenience and value. Together, the two companies will offer employers a new pharmacy network solution that: Provides eligible OptumRx members the option to fill 90-day prescriptions at prices equal to home delivery copay levels at CVS locations nationwide or through OptumRx home delivery; Increases consumer engagement and improves health outcomes through the combination of OptumRx's leading pharmacy and clinical solutions with CVS Pharmacy's leading in-store health and wellness capabilities; Enables OptumRx and CVS Pharmacy to leverage a shared pharmacy platform to develop new pharmacy and health solutions for clients and consumers. OptumRx and CVS expect the new 90-day pharmacy solution to be available to OptumRx commercial clients implementing new 90-day prescription benefit designs, beginning July 1, 2017.

CVS

CVS Health

$74.78

0.72 (0.97%)

UNH

UnitedHealth

$152.11

-0.7 (-0.46%)

  • 29

    Nov

CVS CVS Health
$74.78

0.72 (0.97%)

10/06/16
10/06/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boeing (BA) initiated with an Outperform at Baird. 2. AMC Networks (AMCX) initiated with an Outperform at FBN Securities. 3. CVS Health (CVS) initiated with a Buy at UBS. 4. L-3 Communications (LLL) initiated with an Outperform at Baird. 5. Raytheon (RTN) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/13/16
LEER
10/13/16
NO CHANGE
Target $105
LEER
Outperform
Tricare announcement not material to CVS Health, says Leerink
Leerink analyst David Larsen notes that Tricare recently announced that CVS Health (CVS) will be excluded from its network effective December 1 and Walgreens Boots Alliance (WBA) will be in-network. While there are over 127M scripts associated with Tricare each year, the analyst estimates that just about 30.6M of these prescriptions are "retail" and as a result Larsen does not believe that CVS' exclusion from the Tricare network will be material. He remains positive on CVS, and reiterates an Outperform rating and $105 price target on the company's shares.
11/09/16
COWN
11/09/16
NO CHANGE
Target $86
COWN
Outperform
CVS Health weakness a buying opportunity, says Cowen
Cowen analyst Charles Ryhee said he would be a buyer of CVS Health on weakness. He said he expects little downside risk to management's guidance and wouldn't be surprised to see upside from PBM given the strong selling season. Ryhee maintained his Outperform rating and lowered his price target to $86 from $105 on CVS Health shares.
11/15/16
LEER
11/15/16
NO CHANGE
Target $85
LEER
Outperform
CVS Health price target lowered to $85 from $105 at Leerink
Leerink analyst David Larsen lowered his price target for CVS Health (CVS) to $85 from $105 as he is incrementally more cautious on the company. Conversely, the analyst is incrementally more positive on Walgreens Boots Alliance (WBA) and believes its deal with Rite Aid (RAD) deal is more likely to go through with Trump as President. Nonetheless, Larsen believes that 2017 is largely a re-set year for CVS Health, and expects the business to return to more robust growth in 2018 and beyond. He reiterates an Outperform rating on CVS Health's shares.
UNH UnitedHealth
$152.11

-0.7 (-0.46%)

10/19/16
LEER
10/19/16
NO CHANGE
Target $175
LEER
Outperform
UnitedHealth price target raised to $175 from $165 at Leerink
Leerink analyst Ana Gupte raised her price target for UnitedHealth to $175 from $165 after the company reported a "solid beat and raise" Q3, giving her more confidence in the strength of the company's diversified platform and execution while also offering positive read-across for Commercial Fully Insured & Individual fundamentals to the rest of the group. The analyst reiterates an Outperform rating on the shares.
11/09/16
MZHO
11/09/16
DOWNGRADE
MZHO
Neutral
UnitedHealth downgraded to Neutral from Buy at Mizuho
11/09/16
BERN
11/09/16
NO CHANGE
BERN
Health insurers to see multiple catalysts from Trump presidency, says Bernstein
Bernstein analyst Lance Wilkes says that "repealing and replacing Obamacare will be Trump's primary focus." The analyst expects health insurers to benefit from from the repeal of ACA taxes and the elimination of requirements to spend a certain percentage of revenue on medical costs. Wilkes expects Anthem (ANTM) and Blue Cross/Blue Shield providers to benefit from the elimination of public exchanges and broad coverage requirements. Other health insurers include Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
11/09/16
MZHO
11/09/16
DOWNGRADE
Target $135
MZHO
Neutral
UnitedHealth downgraded to Neutral on Republican win at Mizuho
As previously reported, Mizuho analyst Sheryl Skolnick downgraded UnitedHealth to Neutral from Buy citing Donald Trump's election and the move to a GOP Congress. Following the election results, Skolnick sees an "extreme risk" for the ACA to be repealed and replaced and for the loss of the Medicaid expansion, both of which she notes have been primary drivers of results for hospitals and health plans. She cut her price target on the stock to $135 from $169.

TODAY'S FREE FLY STORIES

BPMC

Blueprint Medicines

$27.01

-0.99 (-3.54%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Blueprint Medicines to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CBS

CBS

$60.18

-0.39 (-0.64%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
CBS management to meet with JPMorgan »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 12

    Dec

PLNT

Planet Fitness

$20.02

0.03 (0.15%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Planet Fitness management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 09

    Jan

RMBS

Rambus

$12.76

0.09 (0.71%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Rambus participates in a conference call with JPMorgan »

JPMorgan Alternative…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
UBS economists and strategists hold an analyst/industry conference call »

U.S. Equity &…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
ISM Non-Mfg Index Composite to be reported at 10:00 »

November ISM Non-Mfg…

JCI

Johnson Controls

$45.32

-0.41 (-0.90%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Johnson Controls to hold a meeting »

Strategic Review &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

CNDT

Conduent

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Conduent to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

VCRA

Vocera

$17.96

0.07 (0.39%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Vocera management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Barclays commodities/energy analysts hold an analyst/industry conference call »

Commodities Analysts…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

Chicago Federal Reserve…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Juno Therapeutics to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TKPPY

Technip

$17.80

0.45 (2.59%)

, FTI

FMC Technologies

$35.60

0.9 (2.59%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
FMC Technologies to host special shareholder meeting »

Special Shareholder…

TKPPY

Technip

$17.80

0.45 (2.59%)

FTI

FMC Technologies

$35.60

0.9 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

TGTX

TG Therapeutics

$5.50

0.05 (0.92%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
TG Therapeutics to hold an investor and analyst reception »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
JPMorgan Euro & global equity strategist holds analyst/industry conference call »

European & Global…

CSV

Carriage Services

$27.50

0.21 (0.77%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Carriage Services management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

Chicago Federal Reserve…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

GNMSF

Genmab

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Genmab to hold data review meeting »

Management discusses data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

RHHBY

Roche

$27.20

-0.1 (-0.37%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Roche to hold an analyst meeting »

Analyst Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

BSFT

BroadSoft

$40.30

-0.35 (-0.86%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
BroadSoft to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CLF

Cliffs Natural

$9.56

0.32 (3.46%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Cliffs Natural management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.